Moderna Inc
NASDAQ:MRNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
C
|
China Starch Holdings Ltd
F:46C1
|
HK |
|
W
|
Wabash National Corp
XBER:WA9
|
US |
|
A
|
Alphabet Inc
MIL:GOOG
|
US |
|
Eiffage SA
PAR:FGR
|
FR |
|
T
|
thyssenkrupp AG
XMUN:TKA1
|
DE |
|
L
|
Lucara Diamond Corp
F:LKT
|
CA |
|
Franchise Brands PLC
LSE:FRAN
|
UK |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
S
|
SSE PLC
DUS:SCT
|
UK |
|
M
|
Markel Corp
XBER:MKV
|
US |
|
Hermes International SCA
F:HMI
|
FR |
|
L
|
Laurent Perrier SA
F:LPE
|
FR |
|
CBAK Energy Technology Inc
NASDAQ:CBAT
|
CN |
|
G
|
Green Plains Inc
XMUN:G3V
|
US |
|
M
|
Murray & Roberts Holdings Ltd
JSE:MUR
|
ZA |
|
T
|
Thales SA
LSE:0IW5
|
FR |
Shareholder Yield
Current shareholder yield for MRNA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
MRNA Price
Moderna Inc
| Average Annual Return | -37.85% |
| Standard Deviation of Annual Returns | 17.72% |
| Max Drawdown | -95% |
| Market Capitalization | 23.7B USD |
| Shares Outstanding | 396 790 000 |
| Percentage of Shares Shorted | 18.09% |
